CyDex Pharmaceuticals Cancels IPO

Published: Oct 29, 2008

Private Equity Hub - Oct 29, 2008 - CyDex Pharmaceuticals Inc., a Lenexa, Kansas-based developer of drugs that “address limitations of current therapies in selected established,” has withdrawn registration of its $50 million IPO. It had planned to trade on the Nasdaq, with Pacific Growth Equities serving as lead underwriter.

Back to news